Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
-463.15%EBIT Margin
VS
Market
Sector
Industry
History
$ 0.8Close
$ 0.58 - $ 1.87 52-Week Range
Ticker Information
Ticker
CUECompany Name
CUE BIOPHARMA INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQCUE BIOPHARMA INC - EBIT Margin Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
CUE - EBIT % Historical data
| Date | Earning Before Interest & Taxes (EBIT) | EBIT Margin | Revenues |
|---|---|---|---|
| 6/30/2025 | $ -38.38M | -463.15% | $ 8.29M |
| 3/31/2025 | $ -39.9M | -499.31% | $ 7.99M |
| 12/31/2024 | $ -39.88M | -429.4% | $ 9.29M |
| 9/30/2024 | $ -43.46M | -455.95% | $ 9.53M |
| 6/30/2024 | $ -45.71M | -550.96% | $ 8.3M |
| 3/31/2024 | $ -48.7M | -693.8% | $ 7.02M |
| 12/31/2023 | $ -49.49M | -901.42% | $ 5.49M |
| 9/30/2023 | $ -50.64M | -1325.7% | $ 3.82M |
| 6/30/2023 | $ -50.76M | -2838.37% | $ 1.79M |
| 3/31/2023 | $ -50.81M | -11754.37% | $ 432.23K |
Key Performance Insights, Last 5 Years
- CUE BIOPHARMA INC's latest trailing twelve months (TTM) EBIT % stands at -1142.59%.
- Over the past 5 years, CUE BIOPHARMA INC's average EBIT % has been -1539.63%.
- The median EBIT % for CUE BIOPHARMA INC during this period was -672.73%
- CUE BIOPHARMA INC reached its highest EBIT % over the past 5 years at -292.25%.
- The lowest EBIT % recorded by CUE BIOPHARMA INC in the same timeframe -11754.37%
CUE BIOPHARMA INC's EBIT % vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
EBIT % Benchmarks
Similar metrics to Revenues:
- EBITDA Margin - [Calculation] A company’s [EBITDA] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated before interest, taxes, depreciation and amortization.
- Net Margin - [Calculation] A company’s Net Income [NetIncCmn] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated.
- Free Cash Flow Margin - [Calculation] A company’s Free Cash Flow [FCF] as a percentage of [Revenue]. Measures how much cash a company produces for each dollar of revenue generated.
- Revenues - [Income Statement] The sum of revenue generated from all sold goods and rendered services.
- Operating Margin - [Calculation] A company’s operating income [OpInc] as a percentage of [Revenue]. The operating margin measures how much profit a company produces for each dollar of revenue generated, after paying for variable costs such as wages and raw materials.
Definition of EBIT Margin
[Calculation] A company’s [EBIT] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated before interest and taxes.EBIT / Revenues
(=) EBIT % EBIT % for CUE BIOPHARMA INC is calculated as follows: EBIT [ $ -42.6M ] / Revenues [ $ 3.73M ]
(=) EBIT % [ -1142.59% ] CUE - EBIT Margin, Last 5 years
-11754.37%
Minimum
Mar 31, 2023
-292.25%
Maximum
Dec 31, 2021
-1539.63%
Average
-672.73%
Median
EBIT % Benchmark AnalysisMarket
The chart above depicts the distribution of EBIT % for companies in the Total Stock Market. The average EBIT % of the companies is 9.55% with a standard deviation of 23.96%.
The following table provides additional summary stats:
EBIT % in the Market:
| filtered constituents | 3.26K |
|---|---|
| min | -73.16% |
| max | 83.08% |
| average | 9.55% |
| median | 9.01% |
| std | 23.96% |